Medifast, Inc.
MED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $150 | $154 | $148 | $193 |
| - Cash | $100 | $102 | $92 | $91 |
| + Debt | $12 | $13 | $15 | $16 |
| Enterprise Value | $63 | $66 | $70 | $118 |
| Revenue | $89 | $106 | $116 | $119 |
| % Growth | -15.3% | -8.8% | -2.8% | – |
| Gross Profit | $62 | $77 | $84 | $88 |
| % Margin | 69.5% | 72.6% | 72.8% | 74.1% |
| EBITDA | $1 | $3 | $2 | $4 |
| % Margin | 0.9% | 2.8% | 1.7% | 3.3% |
| Net Income | -$2 | $2 | -$1 | $1 |
| % Margin | -2.5% | 2.3% | -0.7% | 0.7% |
| EPS Diluted | -0.21 | 0.22 | -0.07 | 0.07 |
| % Growth | -195.5% | 414.3% | -200% | – |
| Operating Cash Flow | $12 | -$3 | $3 | -$5 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$2 |
| Free Cash Flow | $11 | -$5 | $2 | -$7 |